Skip to content

Clinical trials

Melanoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Country / region: Japan Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20112
20121
20136
20141
201510
20165
20178
20184
20192
20205
20213
20225
20234
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated13
Active, not recruiting11
Recruiting8
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals16
Pfizer9
Bristol-Myers Squibb8
Merck Sharp & Dohme LLC4
AbbVie2
Amgen2
Bayer2
Daiichi Sankyo2
Eli Lilly and Company2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma63
Carcinoma, Non-Small-Cell Lung25
Carcinoma, Renal Cell12
Neoplasms12
Ovarian Neoplasms11
Colorectal Neoplasms10
Squamous Cell Carcinoma of Head and Neck10
Triple Negative Breast Neoplasms8
Head and Neck Neoplasms7
Stomach Neoplasms7

Trials

Showing 51 to 63 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.